| ISIN | CH0364960226 |
|---|---|
| Valor Number | 36496022 |
| Bloomberg Global ID | |
| Fund Name | VF (CH) - Valiant Helvétique Balanced ID |
| Fund Provider |
Valiant Bank
Bern, Switzerland Phone: +41 31 320 91 11 Web: www.valiantbank.ch |
| Fund Provider | Valiant Bank |
| Representative in Switzerland |
Lombard Odier Asset Management (Switzerland) SA Bellevue (Geneva) Phone: +41 22 709 21 11 |
| Distributor(s) | Valiant Bank AG |
| Asset Class | Asset Allocation |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | |
| Peculiarities |
| Current Price * | 120.40 CHF | 08.01.2026 |
|---|---|---|
| Previous Price * | 120.51 CHF | 07.01.2026 |
| 52 Week High * | 120.51 CHF | 07.01.2026 |
| 52 Week Low * | 104.82 CHF | 09.04.2025 |
| NAV * | 120.40 CHF | 08.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 623,498,063 | |
| Unit/Share Assets *** | 364,124,341 | |
| Trading Information SIX | ||
| YTD Performance | +0.82% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| 1 month | +1.73% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 months | +2.60% |
08.10.2025 - 08.01.2026
08.10.2025 08.01.2026 |
| 6 months | +6.26% |
08.07.2025 - 08.01.2026
08.07.2025 08.01.2026 |
| 1 year | +8.39% |
08.01.2025 - 08.01.2026
08.01.2025 08.01.2026 |
| 2 years | +15.84% |
08.01.2024 - 08.01.2026
08.01.2024 08.01.2026 |
| 3 years | +18.42% |
09.01.2023 - 08.01.2026
09.01.2023 08.01.2026 |
| 5 years | +11.02% |
08.01.2021 - 08.01.2026
08.01.2021 08.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Muzinich Enhancedyield S-T HCHF Acc H | 4.70% | |
|---|---|---|
| UBS Gold Index Fund hCHF I-A acc | 4.16% | |
| AXAWF Euro Credit Total Ret I Cap CHF H | 2.81% | |
| FvS Bond Opportunities CHF IT | 2.79% | |
| Novartis AG Registered Shares | 2.79% | |
| Capital Group GlbCorpBd (LUX) Zh-CHF | 2.79% | |
| Roche Holding AG | 2.65% | |
| Nestle SA | 2.56% | |
| UBS Siat | 2.44% | |
| Swiss Rock Emerg Eq/Aktien Schw C | 2.34% | |
| Last data update | 30.11.2025 | |
| TER | 1.21% |
|---|---|
| TER date | 30.04.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.66% |
| Ongoing Charges *** | 1.33% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |